The CURE Act amends section 1003 of the 21st Century Cures Act to require the Secretary of Health and Human Services to develop and implement a standardized system to collect quarterly data from States that receive opioid use disorder grants. States must report how grant funds were spent, describe grant activities, identify ultimate recipients and subrecipients (including name, location, and taxpayer identification number), and report the number of individuals served.
The bill also updates the statute’s required report to Congress to include the activities of recipients and subrecipients and to list every entity receiving funds along with the funding level. The new reporting regime takes effect 180 days after enactment and aims to increase transparency and auditability — but it also shifts administrative duties and raises data-privacy and implementation questions for states, providers, and HHS.
At a Glance
What It Does
The bill requires HHS to build a standardized federal data-collection system and obligates States that receive 21st Century Cures opioid-use disorder grants to submit quarterly reports through that system detailing expenditures, activities, recipients, and the number of people served. It also directs HHS to leverage existing federal grant-tracking systems where feasible.
Who It Affects
Primary targets are State lead agencies that receive grants under section 1003(b), their subrecipients (treatment providers, local governments, nonprofit partners), and HHS offices that operate grant reporting and oversight. Congress and federal auditors gain access to more granular funding and recipient-level information.
Why It Matters
This creates a uniform, recurring federal feed of who gets opioid-related grant money and how it is used — closing information gaps that have complicated oversight and evaluation. At the same time, it introduces new compliance work for states and subrecipients and raises questions about data security and the scope of publicly reportable information.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill changes the reporting structure for opioid-use disorder grants authorized under section 1003 of the 21st Century Cures Act. Rather than leaving data collection ad hoc, it directs the Secretary of HHS to design and run a single, standardized system that states must use.
The statute specifies a regular cadence: states will push quarterly submissions into that system describing prior fiscal-year expenditures, program activities, counts of individuals served, and detailed information on any subrecipients.
A notable mechanical change is the required disclosure of ultimate recipients’ identifiers: the bill mandates that states list the name, physical location, and taxpayer identification number for each subrecipient that receives grant funds. The Secretary must also attempt to avoid duplication by linking or reusing other federal grant-tracking tools “to the extent feasible,” which creates both an integration task and an opportunity to reduce parallel reporting channels.The law also tightens what HHS must include in its statutorily required report to Congress.
That report must describe the activities of recipients and subrecipients and enumerate each entity that received funds along with the amount it received. Policymakers and auditors will therefore see both program activity and a funding map that connects federal awards to downstream organizations.Operationally, the amendments kick in 180 days after enactment.
That window gives HHS and states a short implementation period to build technical connections, adapt state grant-management practices, and update privacy and procurement processes — but it does not appropriate new funds or articulate enforcement mechanisms in the text. The result is a shift toward centralized federal visibility into grant flows and program output, paired with unanswered implementation and privacy questions that states and providers will need to resolve quickly.
The Five Things You Need to Know
The Secretary of HHS must develop and implement a standardized data-collection system for States receiving opioid-use disorder grants under section 1003(b).
States must submit quarterly descriptions through that system of how prior fiscal-year grant funds were expended and the activities supported by those funds.
Quarterly reports must identify ultimate recipients and subrecipients by name, location, and taxpayer identification number (TIN).
The Secretary is required to use other federal grant-tracking systems where feasible to avoid duplicative reporting.
HHS’s statutory report to Congress must list each entity that receives grant funds or is a subrecipient and disclose the funding level provided to each; the statute’s changes apply 180 days after enactment.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Designates the bill as the "Clarity for Opioid-Use Reduction and Expenditures Act" or the "CURE Act." This is purely formal but signals the bill’s focus on expenditure transparency and clarity of reporting.
Create a standardized federal data-collection system
This provision requires the Secretary to design and implement one standardized system for collecting data from States that receive opioid-use disorder grants. Practically, HHS will need to set data formats, transmission methods, authentication, and user roles. The Secretary’s choices will determine how interoperable the system is with existing state systems and what technical and security standards apply.
Quarterly reporting requirements for states
States must use the standardized system to submit quarterly descriptions covering: purposes for which grant funds for the preceding fiscal year were expended; the State’s grant-funded activities; the number of individuals served; and identification of ultimate recipients and subrecipients. The timing language (quarterly submissions tied to preceding fiscal-year expenditures) will require states to reconcile fiscal records on a quarterly cadence and to assemble recipient-level data more frequently than many current grant-management systems expect.
Leverage existing federal grant-tracking systems
The Secretary must, to the extent feasible, make use of other federal grant-tracking systems so States and HHS avoid duplicative inputs. That raises concrete implementation choices: whether to surface this data in SAM/FSRS/Grants.gov interfaces, link to the Federal Financial Report (FFR), or build middleware that synchronizes with state systems. Each approach carries trade-offs for cost, timeline, and data harmonization.
Expand the report to Congress to include recipient-level funding and activities
The required report to Congress must now describe recipient and subrecipient activities and list every entity that receives grant funds, including the funding level for each. This makes the annual statutory report a funding inventory and activity summary rather than a high-level program narrative, increasing transparency for lawmakers and auditors but also expanding the scope of what HHS must compile and validate before publication.
180-day implementation window
The new requirements apply beginning 180 days after enactment. That short window forces HHS and states to prioritize technical hookups, data-locations mapping, and updates to state grant terms to capture subrecipient TINs and locations. The statute does not include a dedicated appropriation for these tasks, so jurisdictions must reallocate resources or request separate funding.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Congress and federal auditors — Gain timely, detailed visibility into how opioid-use disorder grant funds flow from federal awards to subrecipients and the amounts each entity receives, improving oversight and the ability to link spending to outcomes.
- Public health researchers and evaluators — Obtain standardized, regular data on service volumes and funding distribution that can improve program evaluation, comparative analyses across states, and evidence-based policy recommendations.
- Taxpayers and policymakers — Benefit from increased transparency about where federal opioid-related dollars go and how many people are served, which supports accountability for federal investments.
Who Bears the Cost
- State lead agencies — Must collect, validate, and submit quarterly recipient-level financial and activity data (including TINs) and adapt grant contracts and tracking systems, creating additional administrative workload and potential procurement or IT costs.
- Subrecipient providers (including small nonprofits and clinics) — May need to supply sensitive identifiers, locations, and regular activity tallies; smaller organizations could face disproportionate compliance burdens and privacy concerns.
- HHS and grant-management offices — Responsible for building or integrating the standardized system, mapping to existing federal systems, setting security rules, and supporting states, with associated development, maintenance, and staffing costs that the bill does not explicitly fund.
Key Issues
The Core Tension
The central dilemma is transparency versus administrative and privacy costs: the bill advances accountability by forcing standardized, recipient-level disclosure of opioid grant flows, but that same transparency imposes real compliance burdens on states and small providers and raises unresolved data-privacy risks; choosing how far to push visibility without undermining program delivery is the core policy trade-off.
The bill increases downstream transparency by requiring TINs and location data for subrecipients, but it does not specify limits on how HHS may use or publish that information. That raises data-protection and confidentiality questions: TINs are sensitive and can enable detailed financial tracing.
The statute requires reporting the number of individuals served, not individual-level health data, but states and providers will need clear guidance on de-identification, access controls, and release policies to avoid inadvertent privacy breaches.
Another operational tension is created by the timing and scope of reporting. The requirement to submit quarterly descriptions of how prior fiscal-year funds were expended will force states to run reconciliations on a tighter timeline than many current grant-management practices anticipate.
The bill directs HHS to leverage other federal grant-tracking systems "to the extent feasible," but it leaves to HHS the hard technical and policy choices about which systems to tie into, how to harmonize data definitions, and how to fund the necessary integration work. Finally, the statute does not set enforcement mechanisms or penalties for noncompliance, nor does it appropriate funds for system development or state implementation — practical gaps that could slow or distort rollout.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.